RP

Robert Scott Pearsall

AP Acceleron Pharma: 32 patents #6 of 55Top 15%
LR Ludwig Institute For Cancer Research: 1 patents #339 of 611Top 60%
Overall (All Time): #110,211 of 4,157,543Top 3%
32
Patents All Time

Issued Patents All Time

Showing 25 most recent of 32 patents

Patent #TitleCo-InventorsDate
12258380 ALK4:actriib heteromultimers and uses thereof Ravindra Kumar, Asya Grinberg, Dianne Sako, Roselyne Castonguay 2025-03-25
12144860 ALK1 receptor and ligand antagonists and uses thereof Asya Grinberg, John Knopf, Ravindra Kumar, Jasbir Seehra 2024-11-19
12024563 ALK7 antagonists and uses thereof John Knopf, Ravindra Kumar, Asya Grinberg, Dianne Sako, Roselyne Castonguay +2 more 2024-07-02
11827689 ALK7:ActRIIB heteromultimers and uses thereof Ravindra Kumar, Asya Grinberg, Dianne Sako, Roselyne Castonguay, Gang Li +2 more 2023-11-28
11279746 ALK4:ActRIIB heteromultimers and uses thereof Ravindra Kumar, Asya Grinberg, Dianne Sako, Roselyne Castonguay 2022-03-22
11168311 Methods for treating anemia in a subject in need thereof Jasbir Seehra, Ravindra Kumar 2021-11-09
11162085 Methods for treating anemia in a subject in need thereof Jasbir Seehra, Ravindra Kumar 2021-11-02
11155791 Methods for treating anemia in a subject in need thereof Jasbir Seehra, Ravindra Kumar 2021-10-26
11028145 ALK7:actriib heteromultimers and uses thereof Ravindra Kumar, Asya Grinberg, Dianne Sako, Roselyne Castonguay, Gang Li +2 more 2021-06-08
10906958 TGF-beta superfamily type I and type II receptor heteromultimers and uses thereof Ravindra Kumar, Asya Grinberg, Dianne Sako, Roselyne Castonguay 2021-02-02
10889626 Combined use of GDF traps and erythropoietin receptor activators to increase red blood cell levels Jasbir Seehra, Ravindra Kumar 2021-01-12
10829532 Combined use of gdf traps and erythropoietin receptor activators to increase red blood cell levels Jasbir Seehra, Ravindra Kumar 2020-11-10
10829533 Combined use of GDF traps and erythropoietin receptor activators to increase red blood cell levels Jasbir Seehra, Ravindra Kumar 2020-11-10
10738098 ALK4:ActRIIB heteromultimers and uses thereof Ravindra Kumar, Asya Grinberg, Dianne Sako, Roselyne Castonguay 2020-08-11
10689427 Combined use of GDF traps and erythropoietin receptor activators to increase red blood cell levels Jasbir Seehra, Ravindra Kumar 2020-06-23
10377996 Methods of identifying ActRIIB variants Jasbir Seehra, Ravindra Kumar 2019-08-13
10227393 TGF-beta superfamily type I and type II receptor heteromultimers and uses thereof Ravindra Kumar, Asya Grinberg, Dianne Sako, Roselyne Castonguay 2019-03-12
10227392 ALK7:ActRIIB heteromultimers and uses thereof Ravindra Kumar, Asya Grinberg, Dianne Sako, Roselyne Castonguay, Gang Li +2 more 2019-03-12
10196434 ALK4:ActRIIB heteromultimers and uses thereof Ravindra Kumar, Asya Grinberg, Dianne Sako, Roselyne Castonguay 2019-02-05
10131700 Methods for treating refractory anemia with ringed sideroblasts Jasbir Seehra, Ravindra Kumar 2018-11-20
10059756 Compositions comprising ALK1-ECD protein Asya Grinberg, John Knopf, Ravindra Kumar, Jasbir Seehra, Kristian Pietras 2018-08-28
9932379 Isolated nucleotide sequences encoding GDF traps Jasbir Seehra, Ravindra Kumar 2018-04-03
9505813 Use of GDF traps to treat anemia Jasbir Seehra, Ravindra Kumar 2016-11-29
9452197 Antagonists of BMP9, BMP10, ALK1 and other ALK1 ligands, and uses thereof Jasbir Seehra, John Knopf, Asya Grinberg, Ravindra Kumar 2016-09-27
9439945 Isolated nucleotide sequences encoding GDF traps Jasbir Seehra, Ravindra Kumar 2016-09-13